Table 1_Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris.docx by Agata Lesiak (17951854)

Image 3_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.tif by Nana Wang (533812)

Image 2_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.tif by Nana Wang (533812)

Image 1_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.jpeg by Nana Wang (533812)

Average Vehicle Arrival Time on Weekends for a Month. by Zhendong Sun (4723221)

Average Vehicle Arrival Time on Weekdays for a Month. by Zhendong Sun (4723221)

Effect of fasudil on clinical outcomes of pulmonary hypertension: a systematic review and meta-analysis by Wanying Bao (19665769)

“…</p> <p>We conducted a systematic search in several databases. Meta-analysis using odds ratio and mean difference was performed, with an assessment of studies’ quality and pooled evidences.…”

Differential expression of growth-promoting and growth-inhibiting genes optimizes biomass production and seed yield. by Sreya Das (20531295)

Boxplot of the acoustic parameters of <i>Physalaemus cicada</i> in response to wind farm noise. The graphs show that calling males found in the ponds of the most intense noise clas... by Rogério Ferreira de Oliveira (11133750)

Functional principle of a fiber Bragg grating. by Guoli Li (291427)

“…<div><p>To solve the problems of low detection efficiency and inability to adapt to distributed measurement in traditional detection methods, a water temperature field detection system based on a fiber Bragg grating string was designed. …”

Dynamics of PIF4 protein accumulation and autoinhibition in response to temperature. by Sreya Das (20531295)

Fig 6 - by Maryann S. Watson (16879881)

Risk Illustration. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Predictors of SCD. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Clinical outcomes. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Ecological factors associated with TB mortality. by Alemneh Mekuriaw Liyew (9216921)

“…Conversely, higher average wind speed (m/s) (RR = 0.89, 95%CI: 0.82,0.96) was associated with decreased TB incidence. TB incidence and mortality rates were significantly associated with various climatic, socioeconomic, and air quality-related factors. …”

Obesity and Depressed Ejection Fraction. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Kaplan Meier curve. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Study data. by Jie Liu (15128)

“…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …”

Summary of clinical outcomes after 9 months. by Jie Liu (15128)

“…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …”